Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3CNS 2Thoracic 1Lymphoid 1Head & Neck 1

Conditions

Esophagitis 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Anus Neoplasms 1

Interventions

Oxaliplatin 297Fluorouracil 272Bevacizumab 235Gemcitabine 234Leucovorin 212Capecitabine 204pembrolizumab 200Nivolumab 157Irinotecan 156Cisplatin 148Specimen Handling 143Magnetic Resonance Spectroscopy 130130-nm albumin-bound paclitaxel 115Paclitaxel 109durvalumab 104Cetuximab 102Radiotherapy 96atezolizumab 92Biopsy 92Drug Therapy 91Albumin-Bound Paclitaxel 78tislelizumab 77Taxes 73Folfox protocol 68lenvatinib 67Carboplatin 65regorafenib 60Blood Specimen Collection 60trifluridine tipiracil drug combination 52Ipilimumab 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Induction Chemotherapy × Gastrointestinal × 1 year × Clear all
NCT07559045 2026-04-30

Induction Chemo-Immunotherapy + Radiotherapy vs Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Second Affiliated Hospital of Zunyi Medical University

Phase 2 Recruiting
92 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06207981 2025-09-02

KANALRAD

Federation Francophone de Cancerologie Digestive

Phase 3 Recruiting
310 enrolled
Gastrointestinal

Anus Neoplasms

NCT06906887 2025-06-29

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

Medical College of Wisconsin

Phase 2 Recruiting
50 enrolled
Gastrointestinal

Esophageal Neoplasms, Esophagitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡